Established in 1997, the PCRC is a primary care practice-based research network for the academic and community practices within the Duke Health System. PCRC includes more than 70 practices in 9 counties in North Carolina, which represents over 200 primary-care clinicians and 500 clinical staff caring for more than 30,000 patients, with access to a total population of 1.2 million. For the past 25 years, the PCRC has conducted over 100 studies, enrolling more than 8000 patients. Our mission is to operate a community-based research network to:
- Improve health care delivery and patient outcomes
- Provide educational opportunities for clinicians
- Support clinician participation in clinical research
- Generate research to support the practice of evidence-based medicine
Site and Study Coordination
The PCRC aids in site access across therapeutic areas for trials involving ambulatory patients with both chronic and acute disease. Our model consists of a group of dedicated research coordinators and specialists trained by the network office which lives in the Duke Clinical Translational Science Institute (CTSI). PCRC Project Management ensures that study milestones are completed according to timelines. PCRC coordinates contract and financial services for all network practices. Use of this model ensures quality data collection, enhances allocation of site personnel, and protects sites from fiscal responsibility for a full-time study coordinator position.
Dr. Dolor came to the DCRI in 1996 after receiving her medical training at Duke University School of Medicine, including residency and a fellowship in General Internal Medicine. Dr. Dolor is the director of the Primary Care Research Consortium (PCRC), a network of primary-care practices in the Duke University Health System and outlying communities. Her research interests are primary care clinical and outcomes research. She has led or co-led several clinical trials in the primary care setting on hypertension, hyperlipidemia, asthma, otitis, obesity, diabetes, chronic pain, anticoagulation, and vaccines.
Dr. Dolor is a Professor in General Internal Medicine and an assistant professor in the Department of Otolaryngology Head and Neck Surgery at Duke University Medical Center. She is also an adjunct Associate Professor at Vanderbilt University Medical Center.